Keywords: Cardiomyopathy, Hyperpolarized MR (Non-Gas), Heart Failure, Contrast Agent, Contrast Mechanisms, MetabolismUsing hyperpolarized [1-13C]pyruvate MR spectroscopy imaging and cine MRI, we show that targeting cardiometabolic dysregulation with metabolic treatment, such as ketone ester supplementation and/or sodium–glucose cotransporter 2 inhibitor, was effective in improving cardiac function and ameliorating cardiac remodeling in a preclinical model of HFpEF. These results provide a rationale for the assessment of metabolic interventions for patients with HFpEF.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords